Discovery of 4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl- N -propylpyrrolo[1,2- f ][1,2,4]triazine-6-carboxamide (BMS-582949), a Clinical p38α MAP Kinase Inhibitor for the Treatment of Inflammatory Diseases
Liu, Chunjian, Lin, James, Wrobleski, Stephen T., Lin, Shuqun, Hynes, John, Wu, Hong, Dyckman, Alaric J., Li, Tianle, Wityak, John, Gillooly, Kathleen M., Pitt, Sidney, Shen, Ding Ren, Zhang, RosemaryVolume:
53
Langue:
english
Journal:
Journal of Medicinal Chemistry
DOI:
10.1021/jm100540x
Date:
September, 2010
Fichier:
PDF, 1.00 MB
english, 2010
File converter
Plus de résultats de recherche
More benefits 
